PEYE Precision Optics Corp. Inc. featured news, full reports, and detailed charts
Precision Optics Corp. Inc. (PEYE/PEYE.OB) Wrap Up:
Precision Optics Corporation, Inc., together with its subsidiaries, engages in the design, development, and manufacture of medical instruments, micro-optics, and other optical systems primarily in the United States. The company?s medical products comprise endoscopes, which consist of arthroscopes that are used in joint surgery; laryngoscopes for use in the diagnosis of diseases of the larynx; laparoscopes, which are used in abdominal surgery; ENT scopes for ear, nose, and throat procedures; and stereo endoscopes and cameras used in cardiac and general surgery that enable surgeons to visualize the surgical field in 3-D imagery. It also develops autoclavable endoscopes, which can withstand sterilization by autoclave; color night vision devices; ultra-small lenses, prisms, and assemblies; and custom optical medical products. In addition, the company offers components and assemblies, such as image couplers, beamsplitters, and adapters for industrial uses, including the video-monitored examination of various industrial cavities and interiors, as well as borescopes; sub-millimeter optical components and assemblies; and color night vision devices comprising eyepiece lens. Further, it provides lens design, imaging analysis, optical system design, structural design and analysis, prototype production and evaluation, optics testing, and optical system assembly services. The company was founded in 1982 and is based in Gardner, Massachusetts.www.poci.com
19 Employees
Founded in 1982
Precision Optics Corp. Inc. (PEYE:OTC Bulletin Board Market)
LAST $1.35 USD
CHANGE TODAY 0.00 0.00%
VOLUME 978.0
As of 12:14 PM 11/20/09 All times are local (Market data by Reuters is delayed by at least 15 minutes).
Snapshot of Precision Optics Corp. Inc. (PEYE)
|
OPEN
$1.35
|
PREVIOUS CLOSE
$1.35
|
|
|
DAY HIGH
$1.35
|
DAY LOW
$1.35
|
|
|
52 WEEK HIGH
04/20/09 - $5.00
|
52 WEEK LOW
12/29/08 - $0.10
|
|
|
MARKET CAP
1.4M
|
AVERAGE VOLUME 3 mo
80.0
|
|
|
DILUTED EPS TTM
$-0.93
|
SHARES OUTSTANDING
1.0M
|
|
|
PEYE Does Not Pay Dividends
|
P/E TTM
NM
|
|
| K = Thousands M = Millions B = Billions | ||
PEYE Top Compensated Officers
Mr. Richard E. Forkey
Founder, Executive Chairman, Chief Executive ...
Age: 69
Total Annual Compensation: $195.0K
Dr. Joseph N. Forkey
Chief Scientific Officer, Executive Vice Pres...
Age: 41
Total Annual Compensation: $120.0K
Mr. Richard G. Cyr
Optical Shop Manager
Total Annual Compensation: $119.0K
Executives, Board Directors
Compensation as of Fiscal Year 2009.
Key developments for Precision Optics Corp. Inc. (PEYE)
Precision Optics Corp. Inc., Annual General Meeting, Nov 24, 2009
10/28/2009
Precision Optics Corp. Inc., Annual General Meeting, Nov 24, 2009, at 10:00 US Eastern Time. Location: The Colonial Hotel, 625 Betty Spring Road, Gardner, MA 01440, United States. Agenda: To elect one Class I director to hold office for a three-year term and until his respective successor shall have been duly elected and qualified; and to transact such other business as may properly come before the annual meeting and any adjournments or postponements of the annual meeting.
Precision Optics Corp. Inc. Auditor Raises 'Going Concern' Doubt
09/28/2009
Precision Optics Corp. Inc. filed its 10-K on September 28, 2009 for the period ending June 30, 2009. In this report its auditor, Stowe & Degon, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Precision Optics Corp. Inc. Amends its Restated Articles of Organization
12/10/2008
Precision Optics Corp. Inc. announced a 1-for-25 reverse split of the company's common stock. The split will be effective when the market opens on December 11, 2008. The Company has amended its restated Articles of Organization, as amended, to effect the reverse split, which will affect all outstanding shares of Precision Optics Corporation common stock, including those shares underlying outstanding stock options, warrants and other convertible securities immediately prior to the effective date.
PEYE Competitors
| Company | Last | Change | |
| No competitor information is available for PEYE. | |||
| Market data is delayed at least 20 minutes. | |||
Industry Analysis
| Valuation | PEYE | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 0.4x |
|
| Price/Book | 2.9x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 0.1x |
|
|
PEYE |
||
|
PEYE transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
More Recent News About Precision Optics Corp. Inc.
More news for PEYE
PRECISION OPTICS CORPORATION INC Files SEC form 10-Q, Quarterly Report
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations. Important Factors Regarding Forward-Looking Statements This quarterly report on Form 10-Q contains forward-looking statements that involve risks and uncertainties. You should not place undue reliance on these forward-looking statements. Our actual results could differ materially from those anticipated in the forward-looking statements for many reasons, including the risks described in this report and other reports we file with the Securities and Exchange Commission. Although we believe the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made. We do not intend to update any of the forward-looking statements after the date of this report to conform these statements to actual results or to changes in our expectations, except as required by law. The following discussion and analysis should be read in conjunction with the Financial Statements and Notes thereto, and other financial information included elsewhere in this quarterly report on Form 10-Q. Overview We have been a developer and manufacturer of advanced optical instruments since 1982. We design and produce high-quality micro-optics, medical instruments and other advanced optical systems. Our medical instrumentation line includes laparoscopes, arthroscopes and endocouplers and a world-class product line of 3-D endoscopes for use in minimally invasive surgical procedures. We are currently developing specialty instruments incorporating our Lenslock TM technology (patent pending) that ensures lower cost, easier reparability and enhanced durability as compared to other design approaches used in the industry. We are also aggressively pursuing ultra-small instruments, some with lenses less than 1 millimeter, or mm, in diameter, utilizing micro-precision TM lens technology (patent pending). We are c...Click here to read the whole Article (external link)
PRECISION OPTICS CORPORATION INC Financials
Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback Quotes delayed, except where indicated otherwise.Delay times are 15 mins for NASDAQ, 20 mins for NYSE and Amex. See also delay times for other exchanges.Fundamental company data provided by Capital IQ. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. Quotes are updated automatically, but will be turned off after 25 minutes of inactivity. Quotes are delayed at least 15 minutes. Real-...Click here to read the whole Article (external link)
PRECISION OPTICS CORPORATION INC Files SEC form 10-K, Annual Report
ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Important Factors Regarding Forward-Looking Statements This annual report on Form 10-K contains forward-looking statements that involve risks and uncertainties. You should not place undue reliance on these forward-looking statements. Our actual results could differ materially from those anticipated in the forward-looking statements for many reasons, including the risks described in this report and other reports we file with the Securities and Exchange Commission. Although we believe the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made. We do not intend to update any of the forward-looking statements after the date of this annual report to conform these statements to actual results or to changes in our expectations, except as required by law. The following discussion and analysis should be read in conjunction with the Financial Statements and Notes thereto, and other financial information included elsewhere in this annual report on Form 10-K. Table of Contents Overview We have been a developer and manufacturer of advanced optical instruments since 1982. We design and produce high-quality micro-optics, medical instruments and other advanced optical systems. Our medical instrumentation line includes laparoscopes, arthroscopes and endocouplers and a world-class product line of 3-D endoscopes for use in minimally invasive surgical procedures. We are currently developing specialty instruments incorporating our Lenslock™ technology (patent pending) that ensures lower cost, easier reparability and enhanced durability as compared to other design approaches used in the industry. We are also aggressively pursuing ultra-small instruments, some with lenses less than 1 mm in diameter, utilizing micro-precision™ lens technology (patent...Click here to read the whole Article (external link)
PRECISION OPTICS CORPORATION INC Files SEC form 10-Q, Quarterly Report
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations. Important Factors Regarding Forward-Looking Statements This quarterly report on Form 10-Q contains forward-looking statements that involve risks and uncertainties. You should not place undue reliance on these forward-looking statements. Our actual results could differ materially from those anticipated in the forward-looking statements for many reasons, including the risks described in this report and other reports we file with the Securities and Exchange Commission. Although we believe the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made. We do not intend to update any of the forward-looking statements after the date of this report to conform these statements to actual results or to changes in our expectations, except as required by law. The following discussion and analysis should be read in conjunction with the Financial Statements and Notes thereto, and other financial information included elsewhere in this quarterly report on Form 10-Q. Overview We have been a developer and manufacturer of advanced optical instruments since 1982. We design and produce high-quality micro-optics, medical instruments and other advanced optical systems. Our medical instrumentation line includes laparoscopes, arthroscopes and endocouplers and a world-class product line of 3-D endoscopes for use in minimally invasive surgical procedures. We are currently developing specialty instruments incorporating our Lenslock TM technology (patent pending) that ensures lower cost, easier reparability and enhanced durability as compared to other design approaches used in the industry. We are also aggressively pursuing ultra-small instruments, some with lenses less than one millimeter in diameter, utilizing micro-precision TM lens technology (patent pending). We are certifi...Click here to read the whole Article (external link)
PRECISION OPTICS CORPORATION INC Files SEC form 10-Q, Quarterly Report
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations. Important Factors Regarding Forward-Looking Statements This quarterly report on Form 10-Q contains forward-looking statements that involve risks and uncertainties. You should not place undue reliance on these forward-looking statements. Our actual results could differ materially from those anticipated in the forward-looking statements for many reasons, including the risks described in this report and other reports we file with the Securities and Exchange Commission. Although we believe the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made. We do not intend to update any of the forward-looking statements after the date of this document to conform these statements to actual results or to changes in our expectations, except as required by law. The following discussion and analysis should be read in conjunction with the Financial Statements and Notes thereto, and other financial information included elsewhere in this quarterly report on Form 10-Q. Overview We have been a developer and manufacturer of advanced optical instruments since 1982. We design and produce high-quality micro-optics, medical instruments and other advanced optical systems. Our medical instrumentation line includes laparoscopes, arthroscopes and endocouplers and a world-class product line of 3-D endoscopes for use in minimally invasive surgical procedures. We are currently developing specialty instruments incorporating our Lenslock TM technology (patent pending) that ensures lower cost, easier reparability and enhanced durability as compared to other design approaches used in the industry. We are also aggressively pursuing ultra-small instruments, some with lenses less than one millimeter in diameter, utilizing micro-precision TM lens technology (patent pending). We are cert...Click here to read the whole Article (external link)
PRECISION OPTICS CORPORATION INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Amendments to Articl
Show all filings for PRECISION OPTICS CORPORATION INC | Request a Trial to NEW EDGAR Online Pro Form 8-K for PRECISION OPTICS CORPORATION INC 11-Dec-2008Entry into a Material Definitive Agreement, Amendments to Articl Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All...Click here to read the whole Article (external link)
PRECISION OPTICS CORPORATION INC Files SEC form 10-Q, Quarterly Report
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations. Important Factors Regarding Forward-Looking Statements This quarterly report on Form 10-Q contains forward-looking statements that involve risks and uncertainties. You should not place undue reliance on these forward-looking statements. Our actual results could differ materially from those anticipated in the forward-looking statements for many reasons, including the risks described in this report and other reports we file with the Securities and Exchange Commission. Although we believe the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made. We do not intend to update any of the forward-looking statements after the date of this document to conform these statements to actual results or to changes in our expectations, except as required by law. The following discussion and analysis should be read in conjunction with the Financial Statements and Notes thereto, and other financial information included elsewhere in this quarterly report on Form 10-Q. Overview We have been a developer and manufacturer of advanced optical instruments since 1982. We design and produce high-quality micro-optics, medical instruments and other advanced optical systems. Our medical instrumentation line includes laparoscopes, arthroscopes and endocouplers and a world-class product line of 3-D endoscopes for use in minimally invasive surgical procedures. We are currently developing specialty instruments incorporating our Lenslock TM technology (patent pending) that ensures lower cost, easier reparability and enhanced durability as compared to other design approaches used in the industry. We are also aggressively pursuing ultra-small instruments, some with lenses less than one millimeter in diameter, utilizing micro-precision TM lens technology (patent pending). We are certi...Click here to read the whole Article (external link)
Would you like to leave a comment about Precision Optics Corp. Inc. PEYE/PEYE.OB
Find out what social network information about Precision Optics Corp. Inc. are available on RealpenniesWorst 5 - Click here to find out what stocks have been voted down by our visitors and users
Besides Precision Optics Corp. Inc. there is more great information available at Realpennies.com